Development of the new healthcare decision support system integrating multiple value-based criteria including cost-effectiveness

2023 Fiscal Year Final Research Report

• Project/Area Number: 20K10360
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 58010:Medical management and medical sociology-related
• Research Institution: Ritsumeikan University
• Principal Investigator: Shimozuma Kojiro 立命館大学, 生命科学部, 教授 (00248254)
• Co-Investigator(Kenkyū-buntansha): 齋藤 信也 岡山大学, 保健学域, 教授 (10335599) ; 森脇 健介 立命館大学, 生命科学部, 准教授 (10514862) ; 白岩 健 国立保健医療科学院, その他部局等, 上席主任研究官 (20583090) ; 星野 絵里 国立研究開発法人国立成育医療研究センター, 政策科学研究部, 室長 (50598521) ; 兼安 貴子 立命館大学, 生命科学部, 助教 (90875923) ; 堺 琴美 立命館大学, 総合科学技術研究機構, 助教 (30907035)
• Project Period (FY): 2020-04-01 – 2024-03-31
• Keywords: 多基準意思決定分析(MCDA) / 医療技術評価(HTA) / 医療資源配分 / 医療倫理 / 医療政策

Outline of Final Research Achievements

The purpose of thie study was to develop an appropriate way of the multifaceted value assessment in health technology assessment (HTA).　1.We revealed the value criteria which thought much of by Japanese people and healthcare professionals divided for the non-life-threatening and life-threatening diseases.　2.We developed the Japanese version of the EVIDEM framework as one of the multi-criteria decision analyses (MCDA).　3.We introduced ‘the Element of Value in Health Care’ which was discussed and published by ISPOR task force.　4.We investigated the utility values in Japanese patients with COVID-19 and asthma.

Free Research Field

医療技術評価(HTA)

Academic Significance and Societal Importance of the Research Achievements

日本で制度として2019年に始まった医療技術評価（HTA）とそれに基づく医療資源配分における様々な課題を解決した。特に、多角的評価基準の提案と、日本人の効用値データを提供できた。
We resolved the various issues around the HTA and healthcare resource allocation in Japan. Especially we proposed some multifaceted value assessment methods and the evidences for the utility values in Japanese.